Bryan T. Baldasare

Chief Accounting Officer, Meridian Bioscience.

Companies

InMed Pharmaceuticals Inc.Board member May 19, 2022 to Dec 23, 2024¹
Meridian BioscienceChief financial officer Sep 23, 2019 to Dec 22, 2021²
Meridian BioscienceChief Accounting Officer Jan 7, 2019 to Jan 7, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Meridian Bioscience60,929 shares⁴Dec 15, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 15, 2021Shares withheld for tax 1,985 shares at $17.92 of Meridian Bioscience⁴
Nov 15, 2021Granted 32,557 shares of Meridian Bioscience⁵
Nov 15, 2021Shares withheld for tax 3,807 shares at $20.16 of Meridian Bioscience⁶
Nov 15, 2021Other 32,557 shares of Meridian Bioscience⁵
Nov 4, 2021Granted 10,593 shares of Meridian Bioscience⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInMed Pharmaceuticals Inc., Board member
2
SEC EDGARMeridian Bioscience, Chief financial officer
3
SEC EDGARMeridian Bioscience, Chief Accounting Officer
4
SEC EDGARMeridian Bioscience shares after the filing of Dec 15, 2021
5
SEC EDGARForm 4 filed Nov 16, 2021
6
SEC EDGARForm 4 filed Dec 16, 2021
7
SEC EDGARForm 4 filed Nov 8, 2021